Clinical Trials Browser

Phase 3 × Completed × Psoriasis × Clear all

Lymphoma, Follicular, Pruritus, Psoriasis

NCT02762955 2021-09-08

CALYPSO

Phase 3 Completed

344 enrolled

Psoriasis

NCT01815424 2019-04-16

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

Phase 3 Completed

266 enrolled 58 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis

NCT01961609 2019-03-18

SIGNATURE

Phase 3 Completed

235 enrolled 23 charts

Psoriasis

NCT01186744 2018-12-26

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Completed

666 enrolled 110 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis

NCT01241591 2018-12-26

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Completed

1,101 enrolled 46 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis, Plaque, Amyloid

NCT02196701 2018-03-19

CLEAR

Phase 3 Completed

46 enrolled 27 charts

Psoriasis

NCT01313221 2017-03-15

REFINE

Phase 3 Completed

310 enrolled 32 charts

Lymphoid

Lymphoma, Follicular, Psoriasis

NCT01519089 2015-08-13

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Phase 3 Completed

95 enrolled 37 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Psoriasis, Arthritis, Psoriatic

NCT01276639 2014-09-19

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

Phase 3 Completed

901 enrolled 56 charts

Lymphoid

Bronchiolitis Obliterans Syndrome, Lymphoma, Follicular, Pruritus, Psoriasis

NCT00111449 2013-05-15

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis

Phase 3 Completed

600 enrolled

Lymphoid

Lymphoma, Follicular, Psoriasis

Clinical Trials

ADVANCE

CALYPSO

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

SIGNATURE

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

CLEAR

REFINE

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis